<SEC-DOCUMENT>0001437749-24-001062.txt : 20240110
<SEC-HEADER>0001437749-24-001062.hdr.sgml : 20240110
<ACCEPTANCE-DATETIME>20240110080012
ACCESSION NUMBER:		0001437749-24-001062
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20240105
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240110
DATE AS OF CHANGE:		20240110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NovaBay Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001389545
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				680454536
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33678
		FILM NUMBER:		24524883

	BUSINESS ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		(510) 899-8800

	MAIL ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>nby20240108_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:nby="http://www.nby.com/20240105"><head>
	<title>nby20240108_8k.htm</title>

	<!-- Generated by ThunderDome Portal - 1/10/2024 4:55:59 AM -->
<meta http-equiv="Content-Type" content="text/html" /></head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20248K" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20248K" name="dei:EntityCentralIndexKey">0001389545</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="nby-20240105.xsd" xlink:type="simple" />
</ix:references>
<ix:resources>
<xbrli:context id="d20248K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001389545</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-01-05</xbrli:startDate>
<xbrli:endDate>2024-01-05</xbrli:endDate>
</xbrli:period>
</xbrli:context>



</ix:resources>
</ix:header>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>UNITED STATES</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>WASHINGTON, D.C. 20549</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORM</b>&#xa0;<ix:nonNumeric contextRef="d20248K" name="dei:DocumentType"><b>8-K</b></ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CURRENT REPORT</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Pursuant to Section 13 or 15(d) of the</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Securities Exchange Act of 1934</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Date of earliest event reported:</b>&#xa0;<ix:nonNumeric contextRef="d20248K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">January 5, 2024</ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityRegistrantName">NovaBay Pharmaceuticals, Inc.</ix:nonNumeric></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Exact Name of Registrant as Specified in Charter)</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:15.4%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:15.4%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityFileNumber">001-33678</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:15.4%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityTaxIdentificationNumber">68-0454536</ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:15.4%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(State or Other Jurisdiction</b></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>of Incorporation)</b></div>
			</td>
			<td style="vertical-align:top;width:15.4%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Commission File Number)</b></div>
			</td>
			<td style="vertical-align:top;width:15.4%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(I.R.S. Employer</b></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Identification No.)</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityAddressAddressLine1">2000 Powell Street, Suite 1150</ix:nonNumeric>,&#xa0;<ix:nonNumeric contextRef="d20248K" name="dei:EntityAddressCityOrTown">Emeryville</ix:nonNumeric>,&#xa0;<ix:nonNumeric contextRef="d20248K" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric>&#xa0;<ix:nonNumeric contextRef="d20248K" name="dei:EntityAddressPostalZipCode">94608</ix:nonNumeric></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Address of Principal Executive Offices) (Zip Code)</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(<ix:nonNumeric contextRef="d20248K" name="dei:CityAreaCode">510</ix:nonNumeric>)&#xa0;<ix:nonNumeric contextRef="d20248K" name="dei:LocalPhoneNumber">899-8800</ix:nonNumeric></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Registrant</b>&#8217;<b>s telephone number, including area code)</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">&#xa0;</td>
			<td style="width: auto;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">&#xa0;</td>
			<td style="width: auto;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">&#xa0;</td>
			<td style="width: auto;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:bottom;width:16.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration: underline;">Title of Each Class</span></b></div>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration: underline;">Trading Symbol(s)</span></b></div>
			</td>
			<td style="vertical-align:top;width:0.7%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:16.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration: underline;">Name of Each Exchange On Which Registered</span></b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:16.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20248K" name="dei:Security12bTitle">Common Stock</ix:nonNumeric>, par value $0.01 per share</div>
			</td>
			<td style="vertical-align:bottom;width:0.6%;">&#xa0;</td>
			<td style="vertical-align:top;width:11.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20248K" name="dei:TradingSymbol">NBY</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:0.7%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NYSE</ix:nonNumeric>&#xa0;American</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8201;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8201;240.12b-2 of this chapter). Emerging growth company&#xa0;<ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#xa0;&#9744;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#xa0;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 72pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Item</b>&#xa0;<b>1.01</b></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Entry into a Material Definitive Agreement </b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 25pt;">NovaBay Pharmaceuticals, Inc. (&#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and &#8220;NovaBay&#8221;) entered into a License and Distribution Agreement, dated January 5, 2024 (the &#8220;License Agreement&#8221;), with Sonoma Pharmaceuticals, Inc. (&#8220;Sonoma&#8221;), pursuant to which we granted Sonoma an exclusive, non-transferable license to use our Avenova brand for use by Sonoma for the sale, distribution, and marketing of Sonoma&#8217;s eye product Ocudox&#174; and its other eyecare products (&#8220;Sonoma Products&#8221;) in the European Union (the "Territory"). As consideration for this license, Sonoma agreed to pay us a quarterly royalty equal to a percentage of net sales of Sonoma Products sold by Sonoma or its affiliates in the Territory, less any returns, rebates, discounts, sales and value-added taxes, tariff and duties, and costs of delivery. The License Agreement has a two (2) year term and is subject to automatic renewal and customary termination rights. Additionally, either party, upon prior written notice of an agreed upon number of days to the other party, may terminate the License Agreement for any reason.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 25pt;">The foregoing description of the License Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the License Agreement, which is attached as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 72pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Item</b>&#xa0;<b>8.01</b></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Other Events</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:25pt;">On January 9, 2024, we issued a joint press release with Sonoma announcing the License Agreement. A copy of the press release is attached hereto as Exhibit&#xa0;99.1 and incorporated herein by reference.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 72pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Item</b>&#xa0;<b>9.01.</b></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Financial Statements and Exhibits.</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(d)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline;">Exhibits.</span></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: 15%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Exhibit No.</b></div>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Description</b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 15%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10.1&#8224;</div>
			</td>
			<td style="vertical-align: top; width: 85%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_613183.htm" style="-sec-extract:exhibit;">License and Distribution Agreement by and between NovaBay and Sonoma, dated, January 5, 2024&#xa0;</a></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 15%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">99.1</div>
			</td>
			<td style="vertical-align: top; width: 85%;"><a href="ex_613557.htm" style="-sec-extract:exhibit;">Press release issued by NovaBay and Sonoma, dated January 9, 2024</a></td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 15%; text-align: center;">104</td>
			<td style="vertical-align: top; width: 85%;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 15%; border-bottom: 1px solid rgb(0, 0, 0);">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#xa0;</div>
			</td>
			<td style="vertical-align: top; width: 85%;">&#xa0;</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:25pt;">&#8224; Certain schedules and exhibits were omitted as well as certain confidential portions of the agreements by means of marking such portions with brackets (due to such confidential portions not being material and being competitively harmful if publicly disclosed) pursuant to Item 601 of Regulation S-K promulgated by the Securities and Exchange Commission. NovaBay agrees to supplementally furnish a copy of any omitted schedule, exhibit or confidential portions to the Securities and Exchange Commission upon request.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#xa0;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SIGNATURES</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: 50%;">&#xa0;</td>
			<td colspan="2" style="vertical-align: top; width: 2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>NovaBay Pharmaceuticals, Inc.</b></div>
			</td>
			<td style="vertical-align: top; width: 12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&#xa0;</td>
			<td style="vertical-align: top; width: 2%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 36%;">&#xa0;</td>
			<td style="vertical-align: top; width: 12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 36%;">/s/ Justin M. Hall</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&#xa0;</td>
			<td style="vertical-align: top; width: 2%;">&#xa0;</td>
			<td style="vertical-align: top; width: 36%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Justin M. Hall</div>
			</td>
			<td style="vertical-align: top; width: 12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&#xa0;</td>
			<td style="vertical-align: top; width: 2%;">&#xa0;</td>
			<td style="vertical-align: top; width: 36%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Executive Officer and General Counsel</div>
			</td>
			<td style="vertical-align: top; width: 12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&#xa0;</td>
			<td style="vertical-align: top; width: 2%;">&#xa0;</td>
			<td style="vertical-align: top; width: 36%;">&#xa0;</td>
			<td style="vertical-align: top; width: 12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dated: January 10, 2024</div>
			</td>
			<td style="vertical-align: top; width: 2%;">&#xa0;</td>
			<td style="vertical-align: top; width: 36%;">&#xa0;</td>
			<td style="vertical-align: top; width: 12%;">&#xa0;</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex_613183.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html><head>
	<title>ex_613183.htm</title>

	<!-- Generated by ThunderDome Portal - 1/9/2024 3:34:33 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;"><b>Exhibit 10.1</b></p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Certain confidential information contained in this document, marked by brackets, has been omitted because it is both (i)</b>&nbsp;<b>not material and (ii)</b>&nbsp;<b>would be competitively harmful if publicly disclosed.</b></p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>LICENSE AND DISTRIBUTION AGREEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">This License and Distribution Agreement (this &#8220;<b>Agreement</b>&#8221;) is made and entered into as of January 5, 2024, by and between NovaBay Pharmaceuticals, Inc., a Delaware corporation having a principal place of business located at 2000 Powell Street, Suite 1150, Emeryville, California 94608 (&#8220;<b>Licensor</b>&#8221;), and Sonoma Pharmaceuticals, Inc., a Delaware corporation having a place of business at 5445 Conestoga Court, Unit 150, Boulder, Colorado 80301 (&#8220;<b>Licensee</b>&#8221;), and (collectively, the &#8220;<b>Parties</b>,&#8221; or each, individually, a &#8220;<b>Party</b>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 72pt;">WHEREAS, Licensor is the sole and exclusive owner of certain trademarks pertaining to its Avenova Antimicrobial Lid and Lash Solution, or Avenova Spray, as further described in <u>Exhibit A</u> attached hereto (the &#8220;<b>Licensed Marks</b>&#8221;);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">WHEREAS, Licensor wishes to grant to Licensee an exclusive license to use the Licensed Marks for the sale, export, and marketing of Licensee&#8217;s eye care products in the Territories (as defined below), on the terms and conditions set forth below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:72pt;">NOW, THEREFORE, in consideration of the mutual covenants and agreements hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:22pt;">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>License</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>License Grant</u>. Subject to the terms and conditions of this Agreement, Licensor hereby grants to Licensee during the Term (as defined below) an exclusive, non-transferable license (except as expressly permitted herein) to use the Licensed Marks in connection with the sale, distribution, export and marketing of Sonoma&#8217;s Ocudox and other eyecare products, in each case, only within the territories set forth on <u>Exhibit B</u> attached hereto (the &#8220;<b>Territories</b>&#8221;). Licensee may exercise any or all of its rights under this Agreement through one or more of its Affiliates. &#8220;<b>Affiliate</b>&#8221; as used herein means, with respect to any person or entity (a) any other person or corporation directly or indirectly controlling, controlled by, or under common control with a Party to this Agreement, or (b) any partnership, joint venture or other entity directly or indirectly controlled by, controlling, or under common control with, a Party to this Agreement but in each case only for so long as such ownership or control shall continue. For purposes of this definition, the term &#8220;control&#8221; as applied to any person or entity means the possession, directly or indirectly, of the power to direct or cause the direction of the management of that person or entity, whether through ownership of voting securities or otherwise. Licensee may sublicense to its Affiliates, provided that Licensee shall cause all such Affiliates to be bound by the same terms, conditions and obligations under this Agreement and Licensee shall be responsible for compliance by such Affiliates.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<div contenteditable="false" data-applyto="p" data-auto-pgnum="start" data-displaynum="2" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="a" data-prefix="" data-startnum="2" data-suffix="" data-textalign="center">&nbsp;</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">1.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Sublicensing</u>. Licensee shall have the right to grant sublicenses under the license rights granted under Section 1.1 to any of its distributors in the Territories, provided that no such sublicense shall exceed the scope of rights granted to Licensee under this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">1.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Restrictions on Licensor</u>. During the Term, Licensor shall not itself use or grant to any other person or entity any right or license to use any Licensed Mark, or any Trademark similar to or derivative of any Licensed Mark, in connection with the Licensed Products or any products similar to or competitive with the Licensed Products in the Territory.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">1.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Reservation of Rights</u>. The exclusive license granted to Licensee under Section 1.1 is subject to Licensor&#8217;s reserved right to use the Licensed Marks in its business, including in connection with the manufacture, promotion, advertising, distribution, and sale of its Avenova Antimicrobial Lid and Lash Solution, or any products similar to or competitive with the Licensed Products (as defined below), anywhere outside of the Territories.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">1.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Marketing Services</u>. Licensee will use commercially reasonable efforts to market and sell its Ocudox products using the Licensed Marks (the &#8220;<b>Licensed Products</b>&#8221;) in the Territories. Licensor will provide reasonable marketing assistance as reasonably requested by Licensee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:22pt;">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Use of Licensed Marks</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Trademark Notices</u>. Licensee shall comply with all marketing, promotion and packaging requirements under applicable law, and shall display such legends and notices as may be specified in writing by Licensor, as reasonably necessary to maintain the Licensed Marks under applicable law and provide notice of Licensor&#8217;s rights therein.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">2.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Modifications</u>. As between the Parties, Licensor is the sole owner of the Licensed Marks and all goodwill related thereto, and all use of the Licensed Marks hereunder and any goodwill accruing therefrom shall inure solely to the benefit of Licensor; provided, however, that as between the Parties, Licensee owns any improvement, enhancement, or other modification of or derivative work based on any of the Licensed Marks made by or on behalf of Licensee or its distributors in connection with the Licensed Products in the Territory, excluding Licensor's trademark rights in the Licensed Marks.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">2.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Quality</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 51pt;text-indent:36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Quality Standards and Use Guidelines</u>. Licensee acknowledges and is familiar with the high standards and reputation for quality symbolized by Licensed Marks, and Licensee shall use the Licensed Marks in a manner consistent with such quality standards and reputation. Licensee shall comply with Licensor's guidelines and specifications regarding the style, appearance, and usage of the Licensed Marks.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 51pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Quality Control</u>. Licensor may exercise quality control over all uses of the Licensed Marks under this Agreement to maintain the validity of the Licensed Marks and protect the goodwill associated therewith. For the purpose of monitoring Licensee's compliance with Licensor's quality standards and the other requirements set forth in this Section 2.3, prior to any use of any Licensed Marks which has not previously been approved or is not substantially consistent with a previously approved use, Licensee shall deliver a representative sample of the Licensed Product or the packaging, labeling, promotional, advertising, or other materials bearing the Licensed Marks to Licensor for its approval, which approval shall not be unreasonably withheld, conditioned, or delayed.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="2" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 51pt;text-indent:36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Approvals</u>. In the event that Licensor has any objection to any sample provided pursuant to Section 2.3(b), Licensor shall provide written notice to Licensee of such objection in reasonable detail to facilitate cure by Licensee. Approval of any particular use of any Licensed Mark, once given by Licensor, shall continue in effect with respect to such use, and any use substantially consistent therewith, without need for further approval.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:22pt;">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Ownership and Protection of the Licensed Marks</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 51pt;text-indent:36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Acknowledgment of Ownership</u>. Licensee acknowledges that Licensor owns and will retain all right, title, and interest in and to the Licensed Marks subject to the license granted in Section 1.1. All use by Licensee of the Licensed Marks, and all goodwill accruing therefrom, will inure solely to the benefit of Licensor.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 51pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Prosecution and Maintenance</u>. Licensor shall, at its sole expense, file, prosecute, and maintain all applications, registrations, and patents relating to the Licensed Marks. Licensee shall provide, at the request of Licensor and at Licensor's expense, all necessary assistance with such filing, maintenance, and prosecution.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:22pt;">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Enforcement</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">4.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Each Party shall promptly notify the other Party of any actual, suspected, or threatened infringement, misappropriation, or other violation of any Licensed Marks by any third party in the Territories (an &#8220;<b>Infringement</b>&#8221;) of which it becomes aware.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">4.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Licensor shall have the first right, in its discretion, to enforce its rights in any of the Licensed Marks, including to bring action with respect to any Infringement. Notwithstanding the foregoing, if within 30 days following either party's receipt of a notice provided under Section 4.1, Licensor does not initiate legal action with respect to any Infringement, or if Licensor subsequently decides not to proceed with any such action, then Licensee shall have the right, but no obligation, to bring or take any such action as it determines is necessary in its reasonable business judgment to halt any such Infringement and to control the conduct of such enforcement action, including settlement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">4.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Party taking action against any alleged Infringement in accordance with this Section 4 (the "<b>Enforcing Party</b>") shall be responsible for the expenses of such enforcement action, including attorneys' fees, and the other Party shall provide such assistance as may be reasonably requested by the Enforcing Party, at the Enforcing Party's expense, in connection with any such enforcement action (including being joined as a Party to such action as necessary to establish standing). Any monetary recovery resulting from such enforcement action shall first be used to pay the legal expenses of the Enforcing Party and then to reimburse any legal expenses incurred by the other party in cooperating in such action as requested by the Enforcing Party, and any remaining amounts shall belong solely to the Enforcing Party.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="3" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:22pt;">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Recordation of License</u>. Upon Licensee's request, Licensor shall make all necessary filings to record this Agreement in the trademark offices or agencies in any and all countries where it may be required under applicable law, including as a prerequisite to enforcement of the Licensed Marks or enforceability of this Agreement in the courts of such countries, and any recordation fees and related costs and expenses will be at Licensor's expense.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:22pt;">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Payment</u>. As consideration in full for the rights granted herein, Licensee shall pay Licensor a royalty as follows.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">6.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Royalty</u>. On or before the last business day of each fiscal quarter during the term of this Agreement, Licensee shall pay to Licensor a royalty of [________] percent ([________]%) of the Net Sales of Licensed Products sold by Licensee or any Affiliate to any third party during the preceding fiscal quarter. "<b>Net Sales</b>" means the gross amount received by Licensee or any Affiliate for sales of Licensed Products in the Territories, less any returns, rebates, discounts or adjustments, sales, excise, use or value-added taxes, costs of packing, insurance, transport and delivery, tariff duties, and freight and duty charges.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">6.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Royalty Statements</u>. At the same time as payments are made under Section 6.1, Licensee shall submit to Licensor a statement showing the calculation of Net Sales in the relevant fiscal quarter.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">6.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Records</u>. Licensee shall keep complete and accurate books and records of its sales of Licensed Marks as reasonably necessary for the calculation of royalties payable under Section 6.1. Licensee shall make such books and records available during normal business hours for inspection and audit by Licensor (or its authorized representative).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:22pt;">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Confidentiality</u>. In connection with this Agreement each Party may gain access to certain confidential and proprietary information of the other Party, which will be deemed &#8220;Confidential Information&#8221; pursuant to the Mutual Confidentiality and Non-Disclosure Agreement, dated [________________], between the Parties (&#8220;<b>Confidentiality Agreement</b>&#8221;), which continues in full force and effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:22pt;">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Representations and Warranties</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">8.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Mutual Representations and Warranties</u>. Each Party represents and warrants to the other Party that:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 51pt;text-indent:36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; it is duly organized, validly existing, and in good standing as a corporation or other entity as represented herein under the Laws of its jurisdiction of incorporation or organization;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 51pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; it has the full right, power, and authority to enter into this Agreement and to perform its obligations hereunder;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="4" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 51pt;text-indent:36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the execution of this Agreement by its representative whose signature is set forth at the end hereof has been duly authorized by all necessary corporate action of the party; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 51pt;text-indent:36pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; when executed and delivered by such party, this Agreement shall constitute the legal, valid, and binding obligation of such party, enforceable against such party in accordance with its terms.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">8.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Licensor's Representations and Warranties</u>. Licensor represents and warrants that:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 51pt;text-indent:36pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; it is the sole and exclusive legal and beneficial owner of the entire right, title, and interest in and to the Licensed Marks in connection with the Licensed Products in the Territories, provided, however, that the application for such Licensed Marks in the Territory are currently pending review and approval as previously disclosed to Licensee;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 51pt;text-indent:36pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; it is the record owner of the registrations and/or applications as disclosed and set forth on <u>Exhibit A</u>, and all such registrations, when and if issued, shall be valid, subsisting, and in full force and effect;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 51pt;text-indent:36pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; it has not granted and during the Term will not grant any licenses, liens, security interests, or other encumbrances in, to, or under the Licensed Marks in the Territories except for that specific encumbrance specified in the Security Agreement, dated&nbsp;April 27, 2023, among Licensor, its subsidiaries and the holders of the Company&#8217;s Original Issue Discount Senior Secured Convertible Debentures due November 1, 2024;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 51pt;text-indent:36pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to its knowledge, the exercise by Licensee of the rights and license granted under this Agreement will not infringe or otherwise conflict with the rights of any other person;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 51pt;text-indent:36pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to its knowledge, there is no settled, pending, or threatened litigation, opposition, or other claim or proceeding challenging the validity, enforceability, ownership, registration, or use of any Licensed Marks in connection with the Licensed Products in the Territories; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 51pt;text-indent:36pt;">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; it has not brought or threatened any claim against any third party alleging infringement of any Licensed Marks in the Territory, nor, to its knowledge, is any third party infringing or threatening to infringe any Licensed Mark.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:22pt;">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Indemnification</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">9.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>By Licensor</u>. Licensor shall indemnify, defend, and hold harmless Licensee and its Affiliates, officers, directors, employees, agents, sublicensees, successors, and assigns (each, a "<b>Licensee Indemnified Party</b>") from and against all Losses arising out of or in connection with any third-party claim, suit, action, or proceeding ("<b>Third-Party Claim</b>") relating to any actual or alleged: (a) breach by Licensor of any representation, warranty, covenant, or obligation under this Agreement, or (b) infringement, dilution, or other violation of any intellectual property or other personal or proprietary rights of any person resulting from the use of the Licensed Marks by Licensee or any of its Affiliates or sublicensees in accordance with this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="5" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">5</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">9.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>By Licensee</u>. Licensee shall indemnify, defend, and hold harmless Licensor and its Affiliates, officers, directors, employees, agents, successors, and assigns (each, a "<b>Licensor Indemnified Party</b>") from and against all Losses arising out of or in connection with any Third-Party Claim relating to any actual or alleged: (a) breach by Licensee or any Affiliate or sublicensee of any representation, warranty, covenant, or obligation under this Agreement, (b) defect in any Licensed Product, including any product liability claim; or (c) infringement, dilution, or other violation of any intellectual property rights of any Person resulting from the manufacture, promotion, advertising, distribution, and sale of Licensed Products; in each case except to the extent any such Third-Party Claim relates to the use of the Licensed Marks authorized and in accordance with the terms of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">9.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Indemnification Procedure</u>. An Indemnified Party shall promptly notify the party from whom it is seeking indemnification ("<b>Indemnifying Party</b>") upon becoming aware of a Third-Party Claim with respect to which the Indemnifying Party is obligated to provide indemnification under this Section 9 ("<b>Indemnified Claim</b>"). The Indemnifying Party shall promptly assume control of the defense and investigation of the Indemnified Claim, with counsel reasonably acceptable to the Indemnified Party, and the Indemnified Party shall fully cooperate with the Indemnifying Party in connection therewith, in each case at the Indemnifying Party's sole cost and expense. The Indemnified Party may participate in the defense of such Indemnified Claim, with counsel of its own choosing and at its own cost and expense. The Indemnifying Party shall not settle any Indemnified Claim on any terms or in any manner that adversely affects the rights of any Indemnified Party without the Indemnified Party's prior written consent (which consent shall not be unreasonably withheld, conditioned, or delayed. The Indemnified Party's failure to perform any obligation under this Section 9.3 nor any act or omission of the Indemnified Party in the defense or settlement of any Indemnified Claim shall not relieve the Indemnifying Party of its obligations under this Section 9, except to the extent that the Indemnifying Party can demonstrate that it has been materially prejudiced as a result thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:22pt;">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Limitation of Liability</u>. EXCEPT FOR LICENSEE'S LIABILITY FOR INDEMNIFICATION UNDER SECTION 9, NEITHER PARTY WILL BE LIABLE TO THE OTHER PARTY OR ANY THIRD PARTY FOR ANY CONSEQUENTIAL, INCIDENTAL, INDIRECT, EXEMPLARY, SPECIAL, OR PUNITIVE DAMAGES RELATING TO THIS AGREEMENT OR USE OF THE LICENSED MARKS HEREUNDER, WHETHER ARISING OUT OF BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, REGARDLESS OF WHETHER SUCH DAMAGE WAS FORESEEABLE AND WHETHER SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:22pt;">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Term and Termination</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">11.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Term</u>. The term of the Agreement shall be for an initial period of two (2) years from the effective date of the Agreement (the &#8220;<b>Initial Term</b>&#8221;), to be renewed automatically thereafter (the Initial Term, together with subsequent renewal periods, the &#8220;<b>Term</b>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="6" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">6</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">11.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Termination</u>. Either Party may terminate this Agreement:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 51pt;text-indent:36pt;">(a) immediately if the other Party materially breaches this Agreement and fails to cure such breach within [_______] ([_________]) days after receiving written notice thereof;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 51pt;text-indent:36pt;">(b) immediately if the other Party shall seek protection under any bankruptcy, receivership, trust deed, creditors arrangement, composition, or comparable proceeding, or if any such proceeding is instituted against the other (and not dismissed within [_______] ([_________]) days;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 51pt;text-indent:36pt;">(c) for any reason upon [_______] ([_________]) days written notice to the other Party; or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 51pt;text-indent:36pt;">(d) by mutual written agreement of the Parties.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">11.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Sell-Off Period</u>. Upon expiration or termination of this Agreement, Licensee shall have the right to dispose of all stocks of Licensed Products bearing the Licensed Marks in its possession or in the course of manufacture or production as of the date of expiration or termination for a period of [_______] ([_________]) days after the date of expiration or termination (the "<b>Sell-Off Period</b>"), in each case, in accordance with the terms and conditions of this Agreement. Any royalty or other payment accruing during the Sell-Off Period under the provisions of Section 6 shall be paid to Licensor within [_______] ([_________]) days after the expiration of the Sell-Off Period.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">11.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Survival</u>. The rights and obligations of the parties set forth in Section 7 (Confidentiality), Section 8 (Representations and Warranties), and Section 9 (Indemnification), and Section 13 (General Provisions), and any right, obligation, or required performance of the parties in this Agreement which, by its express terms or nature and context is intended to survive termination or expiration of this Agreement, will survive any such termination or expiration.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:22pt;">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Assignment</u>. Neither Party assign or transfer any of its rights or obligations under this Agreement other than to one of its Affiliates without the other Party's prior written consent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:22pt;">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>General Provisions</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">13.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Amendments</u>. No amendment to this Agreement will be effective unless it is in writing and signed by both Parties.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">13.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>No Third-Party Beneficiaries</u>. Except for the right of each Party's Affiliates, officers, directors, employees, agents, and representatives to enforce their rights to indemnification under Section 9, this Agreement solely benefits the Parties and their respective permitted successors and assigns and nothing in this Agreement, express or implied, confers on any other person any legal or equitable right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="7" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">7</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">13.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Counterparts</u>. This Agreement may be executed in counterparts, each of which is deemed an original, but all of which together are deemed to be one and the same agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">13.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Severability</u>. If any term or provision of this Agreement is invalid, illegal, or unenforceable in any jurisdiction, such invalidity, illegality, or unenforceability will not affect any other term or provision of this Agreement or invalidate or render unenforceable such term or provision in any other jurisdiction.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">13.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Governing Law</u>. This Agreement, including all exhibits, schedules, attachments, and appendices attached to this Agreement and thereto, and all matters arising out of or relating to this Agreement, are governed by, and construed in accordance with, the laws of the State of Colorado, without regard to the conflict of laws provisions thereof to the extent such principles or rules would require or permit the application of the laws of any jurisdiction other than those of the State of Colorado.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">13.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Waiver</u>. Except as otherwise set forth in this Agreement, no failure to exercise, or delay in exercising, any rights, remedy, power, or privilege arising from this Agreement will operate or be construed as a waiver thereof, nor will any single or partial exercise of any right, remedy, power, or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power, or privilege.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">13.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Notices</u>. All correspondence or notices required or permitted to be given under this Agreement must be in writing, in English and addressed to the other Party at its address set out below (or to any other address that the receiving Party may designate from time to time). Each Party shall deliver all notices by personal delivery, nationally recognized overnight courier (with all fees prepaid), facsimile or email (with confirmation of transmission) or certified or registered mail (in each case, return receipt requested, postage prepaid). Except as otherwise provided in this Agreement, a notice is effective only (a) upon receipt by the receiving Party; and (b) if the Party giving the notice has complied with the requirements of this Section. Such communications must be sent to the respective Parties at the following addresses (or at such other address for a Party as specified in a notice given in accordance with this Section 13.7):</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:75.5882352941177%;margin-left:0pt;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:37.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 18pt;">&nbsp; If to Licensor:</p>
			</td>
			<td style="vertical-align:top;width:65.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">5445 Conestoga Court, Suite 150</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Boulder, Colorado 80301</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Facsimile:<br>
			Email:</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Attention:</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:37.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 18pt;">&nbsp; If to Licensee:</p>
			</td>
			<td style="vertical-align:top;width:65.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2000 Powell Street, Suite 1150</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Emeryville, California 94608<br>
			Facsimile:<br>
			Email:<br>
			Attention:</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 22pt;text-indent:29pt;">13.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Entire Agreement</u>. This Agreement, including and together with any related exhibits, schedules, attachments, and appendices, and the Confidentiality Agreement constitute the sole and entire agreement of Licensor and Licensee with respect to the subject matter contained herein, and supersede all prior and contemporaneous understandings, agreements, representations, and warranties, both written and oral, regarding such subject matter.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">[SIGNATURE PAGE FOLLOWS]</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="8" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;">IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the date first written above by their respective officers thereunto duly authorized.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="text-indent: 0; width: 100%;font-family: 'Times New Roman', Times, serif; font-size: 10pt">

		<tr>
			<td style="width: 50%;" valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td colspan="2" style="width: 2%;" valign="top" width="38%">SONOMA PHARMACEUTICALS, INC.</td>
			<td style="width: 12%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="width: 2%;" valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td align="left" nowrap="nowrap" style="width: 36%;" valign="bottom" width="35%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="width: 12%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td align="left" style="text-align: left; width: 50%;" valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="text-align: left; width: 2%;" valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">By </font></p>
			</td>
			<td align="left" nowrap="nowrap" style="border-bottom: 1px solid rgb(0, 0, 0); width: 36%;" valign="top" width="35%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp; /s/&nbsp;</font>Amy Trombly</p>
			</td>
			<td style="width: 12%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td colspan="2" rowspan="1" style="width: 2%;" valign="top" width="3%">
			<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Name: Amy Trombly</p>
			</td>
			<td style="width: 12%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td colspan="2" rowspan="1" style="width: 2%;" valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Title: Chief Executive Officer</p>
			</td>
			<td style="width: 12%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="text-indent: 0; width: 100%;font-family: 'Times New Roman', Times, serif; font-size: 10pt">

		<tr>
			<td style="width: 50%;" valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td colspan="2" style="width: 2%;" valign="top" width="38%">NOVABAY PHARMACEUTICALS, INC.</td>
			<td style="width: 12%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="width: 2%;" valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td align="left" nowrap="nowrap" style="width: 36%;" valign="bottom" width="35%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="width: 12%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td align="left" style="text-align: left; width: 50%;" valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="text-align: left; width: 2%;" valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">By </font></p>
			</td>
			<td align="left" nowrap="nowrap" style="border-bottom: 1px solid rgb(0, 0, 0); width: 36%;" valign="top" width="35%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp; /s/&nbsp;</font>Justin Hall</p>
			</td>
			<td style="width: 12%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td colspan="2" rowspan="1" style="width: 2%;" valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Name: Justin Hall</p>
			</td>
			<td style="width: 12%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td colspan="2" rowspan="1" style="width: 2%;" valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Title: CEO</p>
			</td>
			<td style="width: 12%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="9" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">9</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex_613557.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_613557.htm</title>

	<!-- Generated by ThunderDome Portal - 1/9/2024 7:19:41 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 99.1</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">
			<div><img alt="logo01.jpg" src="logo01.jpg"></div>
			</td>
			<td style="width: 50%; text-align: right;">
			<div><img alt="logo02.jpg" src="logo02.jpg"></div>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; text-align: center; margin: 0pt;"><b>NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma</b>&#8217;<b>s Extensive Distributor Network</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>EMERYVILLE, Calif. and BOULDER, Colo. (January 9, 2024) </b>&#8211; NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) and Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA) today announced an agreement for the sale and marketing of Avenova&#174;-branded products by Sonoma in the European Union. The new products will combine Sonoma&#8217;s existing eye product Ocudox&#174;, which has already received a Class IIB CE mark for sale in the European Union, with Avenova branding, and are expected to be marketed through Sonoma&#8217;s established European distribution network. This agreement brings together NovaBay&#8217;s deep knowledge of eye care reflected in its Avenova brand with Sonoma&#8217;s expertise in distributing hypochlorous acid products overseas.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Sonona will manufacture Ocudox by Avenova with packaging similar to NovaBay&#8217;s Avenova products, which are the leading hypochlorous acid-based eye care products in the U.S. Sonoma will pay NovaBay a royalty fee based on net product sales of Ocudox by Avenova, and Sonoma will continue to market its Ocudox product in the European Union.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;Sonoma has built a strong and growing presence in the European Union through a network of distributors and direct sales. We are excited to add Avenova-branded products to our offerings. At the same time, NovaBay has built strong brand recognition for Avenova in the dry eye market in the United States that we believe will resonate internationally,&#8221; said Amy Trombly, CEO of Sonoma. &#8220;Ocudox sales in the European Union are already an important component of our business, and we see plenty of room to expand our eye care offerings. We are excited to partner with NovaBay on this opportunity, which we believe will allow more people to benefit from a quality hypochlorous acid product to aid in the treatment and symptoms of blepharitis on the eyelid.&#8221;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;We are delighted that NovaBay will now be able to capitalize on sales of hypochlorous acid eye care products in the European Union. Sonoma&#8217;s CE mark includes a claim of treating blepharitis, the inflammation that typically affects the edges of the eyelids when tiny oil glands near the base of the eyelashes become clogged, causing irritation and redness. We&#8217;ve long asserted that blepharitis can lead to complications such as dry eye,&#8221; said Justin Hall, CEO and General Counsel of NovaBay. &#8220;The EU market is comparable in size to the U.S., giving NovaBay the opportunity to double its sales of Avenova. NovaBay will continue to be the exclusive seller of Avenova branded products in the U.S.&#8221;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>About Ocudox</b></p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Ocudox is a patented solution intended to support the treatment of blepharitis and the daily hygiene of eyelids and eyelashes. Ocudox cleans the eye lids, lashes and periocular skin and assists in removing debris and microorganisms that can cause irritation and ocular surface disease. The solution does not contain any harmful chemicals, and there is no preparation required prior to application and no need to rinse after use. Ocudox is non-irritating, non-sensitizing, no stinging, no burning and has no contraindications. Ocudox is suitable for contact lens wearers.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>About Sonoma Pharmaceuticals, Inc.</b></p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. The company's products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. <i>In vitro </i>and clinical studies of HOCl show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma's stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated, thereby assisting the body in its natural healing process. The company's products are sold either directly or via partners in 55 countries worldwide and the company actively seeks new distribution partners. The company has its corporate headquarters in Boulder, Colorado and manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands. More information can be found at<u> </u><u>www.sonomapharma.com</u>. For partnership opportunities, please contact <u>busdev@sonomapharma.com</u>.<u> </u></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>About NovaBay Pharmaceuticals, Inc.:</b></p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">NovaBay Pharmaceuticals, Inc. develops and sells scientifically created and clinically proven eyecare, skincare and wound care products. NovaBay&#8217;s leading product Avenova&#174; Antimicrobial Lid &amp; Lash Solution is often prescribed by eyecare professionals for blepharitis and dry<u>-</u>eye disease and is also available directly to consumers through online distribution channels such as Amazon. DERMAdoctor&#174; offers more than 30 dermatologist-developed skincare products through the DERMAdoctor website, well-known traditional and digital beauty retailers, and international distributors. NovaBay also manufactures and sells effective, yet gentle and non-irritating wound care products. The PhaseOne&#174; brand is distributed through commercial partners in the U.S. for professional use only, and the NeutroPhase&#174; brand is distributed in China by China Pioneer Pharma Holdings, Limited. More information about NovaBay is available here.<u> </u></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Forward-Looking Statements</b></p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Except for historical information herein, matters set forth in this press release are forward-looking within the meaning of the &#8220;safe harbor&#8221; provisions of the Private Securities Litigation Reform Act of 1995, including statements about the commercial and technology progress and future financial performance of Sonoma Pharmaceuticals, Inc., NovaBay Pharmaceuticals, Inc. and their respective subsidiaries. These forward-looking statements are identified by the use of words such as &#8220;continue,&#8221; &#8220;develop,&#8221; &#8220;anticipate,&#8221; &#8220;expect" and &#8220;expand,&#8221; among others. Forward-looking statements in this press release are subject to certain risks and uncertainties inherent in the companies&#8217; respective businesses that could cause actual results to vary, including such risks that regulatory clinical and guideline developments may change, scientific data may not be sufficient to meet regulatory standards or receipt of required regulatory clearances or approvals, clinical results may not be replicated in actual patient settings, protection offered by patents and patent applications may be challenged, invalidated or circumvented by its competitors, the available market for products will not be as large as expected, products will not be able to penetrate one or more targeted markets, revenues will not be sufficient to meet cash needs or fund further development, as well as uncertainties relative to the recent pandemic and economic development, varying product formulations and a multitude of diverse regulatory and marketing requirements in different countries and municipalities, and other risks detailed from time to time in each company&#8217;s filings with the Securities and Exchange Commission. The forward-looking statements in this release speak only as of this date, and NovaBay and Sonoma each disclaims any intent or obligation to revise or update publicly any forward-looking statement except as required by law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Sonoma Pharmaceuticals<sup style="vertical-align:top;line-height:120%;">TM</sup> and Ocudox&#174; are trademarks or registered trademarks of Sonoma Pharmaceuticals, Inc. NovaBay&#174; and Avenova&#174; are trademarks or registered trademarks of NovaBay Pharmaceuticals, Inc. All other trademarks and service marks are the property of their respective owners.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><u>NovaBay Pharmaceuticals Contacts </u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>At the Company</u></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Justin Hall</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Chief Executive Officer and General Counsel</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Phone: 510-899-8800</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Website: <u>www.novabay.com</u></p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Email:<u>sales@novabay.com</u></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Twitter: @NovaBayPharma</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>Investor Contact </u></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">LHA Investor Relations</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Jody Cain</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Phone: 310-691-7100</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Email:&nbsp;<u>jcain@lhai.com</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><u>Sonoma Pharmaceuticals Contacts</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>At the Company</u></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Amy Trombly</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Chief Executive Officer and General Counsel</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Website: <u>www.sonomapharma.com</u><u> </u></p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Email:<u>busdev@sonomapharma.com</u><u> </u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>Investor Contact </u></p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Email:<u>ir@sonomapharma.com</u><u> </u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">#&nbsp; #&nbsp; #</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>nby-20240105.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 1/10/2024 4:56:06 AM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:nby="http://www.nby.com/20240105" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.nby.com/20240105">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nby-20240105_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nby-20240105_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nby-20240105_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.nby.com/20240105/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="nby_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>nby-20240105_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 1/10/2024 4:56:06 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.nby.com/20240105/role/statement-document-and-entity-information" xlink:href="nby-20240105.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.nby.com/20240105/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>nby-20240105_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 1/10/2024 4:56:06 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>nby-20240105_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 1/10/2024 4:56:06 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.nby.com/20240105/role/statement-document-and-entity-information" xlink:href="nby-20240105.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.nby.com/20240105/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>logo01.jpg
<TEXT>
begin 644 logo01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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MX'W6786.&PT*$5:R7W]?Q/Q4_P""G_\ P5X'C<ZQ9Z1XB\4F&35K_2-"\/\
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M ,&LGPW\57CS^#/B/XO\-KR4M=5MH=8A0^@;]U(!]6)]Z]7"TL#45JU64/\
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<JM:I5FZE5MM]6=-&C3I05.E%)+H@HHHK,T/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>logo02.jpg
<TEXT>
begin 644 logo02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  F ,T# 2(  A$! Q$!_\0
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M/Y0?$3QA\0/^"CW[6$6D:==L8K^[DM]%LKF1A:Z98IDER!T.Q=[$#+,<>@H
M_9?P5^VI\#?B'KL6C:!\3=!O-3F;;%;R3F R-Z*9 H8GL!G->PZIJEGH>FW6
MH:A=0V-A:QM-/<W#A(XD499F8\  #.37XB_M6?\ !+/Q1^S;\+)?'FG>*[;Q
M=ING>7_:L,=HUM+;!F"^8GS,'0,5!Z$9SCKCV[]CC]IO7/C!^Q!\;O GBF^F
MU75?"?ARY:SOKAB\DEE)!(%1V/WBC(0">=K =J /T3\/?M$_"[Q9'J4FC?$+
MPWJ4>FVQO+U[?5(66VA! ,DAW?*H) R>.17->$?VSO@AX\\3Q>'M"^)F@WVL
M2OY<5M]H,?FM_=1G 5B>P!.>U?A9^R/^SCXF_:E^*#^"/#^K+H=K)9M=:I?2
MEC'';(Z=44CS"7*84\9P>,9KJ/VU/V*M;_8T\3:!!<:_#XBTC6HY)+'4883;
MR*\17>CIN;!&]""&.<^U ']"=>5?$[]JGX1_!K4AIWC+Q_HNAZEU-E)/YDZ^
M[1H&9?Q KXEU7]N#Q/X'_P""8/@_Q<E\Y\?:R7\-6>I2MNE#1/(C7.2.7$4?
M4_Q$&ODG]C[_ ()^^+OVT-.UKQGJ/BE?#^AQWCV[:G=Q->7-[=8#OA2RY W+
MEF;JW&>: /VN^&/QN\!?&BPEO/ _BW2O$T,/^M%A<!Y(O3>GWE_$"K7CWXN>
M"?A:+,^,/%>C^&?MF[[-_:MY';^=MQNV[B,XW#./45^"_P 4?AO\2_\ @G+^
MT1IIL]95-3ME2_T[5;$LL&H6Q8AD=#U4E2KH<_7H:^B_^"LWQ%M/B]\-_P!G
M;QK91B*WUS2KR^$><^676U+)G_9;(_"@#]//%G[3GPG\#^%]-\1ZW\0= L=%
MU-2UC=F]1Q=*"5)C"Y+@$$$@'!ZUL?"_XU>!/C5I<VH^!O%6F>)K6%MLQL)P
MSQ'L'0X9<]L@9K\=?V7_ /@F1XO_ &HO@W;>.;[QQ#X>LI5DM]$LKFW>Z+HC
ML"6.\>5&7W8"@GJ<<\_./@N3XF? _P"-6J>#O"FK7.A>,I[N;PM<?8IMJRM(
M_DLF?0L00W4<$8(H _>KQ=^V-\$_ OBB3P[KOQ,\/Z?K,;^7+:M=;S$V<;79
M050^H8C'>O6=)U>QU[3;;4=,O+?4=/N4$L%U:RK)%*AZ,K*2"/<5^*W[2W_!
M*CQ#\!/@;>?$-?&UOXDO=+1)M7T];-H@BLP5FBD+DOM9AG<JDC)]J]'_ ."4
M_P"TEJ/@+X,_&FPU>>2]T3P?IG_"16%O,Y(C8K()(E_NJS)'P.Y8]S0!^E7Q
M6_:$^&_P/C@;QUXRTKPV]P-T,%W-F:0>JQ+ER/<#%8OAO]KCX->+O">J>)M*
M^(V@W.B:7M-]<M<^4;8,P52Z. R@L0 2.37X>?"7X7_$3_@H5^T5J$=QK DU
MC4/,U+5-8OMS16=N& ^51V!941!@<@<#)KT?]L[_ ()P>(OV2?!MMXMT_P 4
MIXK\+SS)97TBVQM9K>1N4W)O8,A*XSG@@9'(H _9GPS\?OAWXS\*ZCXET#Q?
MIFM:'ITJPW=[I\OG) YQA6V@D$[AV[UK6OQ4\(WTTL-OX@L9IHAF2-9<M'\[
MQ_,.H.^*1<'NAK\]_P#@BWH]GKWP3^)]A?P+<VD^M0+)$V<,! #V]Q7Z!Z?\
M(_!^DZEJ>H6>@VUO>ZG+Y]Y.F[=.^6.YN?5F_,T ?#?Q.^*FO:+\2/%-@]M9
MYM]3N$&]'SM\PE<_-_=(KF?^%T:Y_P ^UA_W[?\ ^*KV+]L3X-SZ?XR'C&RP
MFFZH%2Z(0D1W &,G'0,H'/J#7SQ_PCK?\_4?_?!K;#\#Y5C::KPP497Z^?7J
M?BV:\8<299C*F%ECII1>G^'IT['2_P#"Z-<_Y]K#_OV__P 51_PNC7/^?:P_
M[]O_ /%5S7_".M_S]1_]\&C_ (1UO^?J/_O@UT_\0]RW_H C_7S/*_XB!Q#_
M -!\_O\ ^ >P? OXG:WXA^+WA73VM[-8YKOYVC1MP4(Q)^]Z"OOZOD#]C'X.
MSP:Q<>.+\9MHHVMM/RA&]FX>09[ ?*#ZD^E?7]>=_9>$RB<L/A*2IKJEW/UG
MA['9EF6!6*S.JZDI/W7+^7I][NS\E?VCO^"GGQ6^#?[7>OV-GH@M_!NBM_9O
M_",ZQ#Y1O44Y-T) -RLYY1AE=NW(/->9_MJ_MZ?"S]JKX2Q:=9_#&YTKQ]]H
MBE36[DPYM54CS%$B?/(&7*[6  SGJ!7ZO?&+X*_"+X^7,6@>/-$T/7]5B0^3
M%-*J7\2D9^1D82*,<\''>O%]-_X):?LU:#K4-S)X5N+F0;I8[.^UFX>-@N,G
M9O!8#(SG(YYJCZ4^./\ @C7\']8\0>,?B#XMN()[?PN^B2:#]H((6>:9T9E7
M^]L5,GT++ZU\N^$?$GB_]@7]K!KNYTSS=7\+WTUM/9W&8TOK5P4)5N<*\;!E
M89ZCKTK^@_P=X9T#P?X9L-)\,:=8Z5H5O$!:VNFQK' J=BH7CGKGO7DO[0/[
M(OPH_:TTNUG\5:8MU>PH4M-?TB<1W4:Y/RB0 JZ@Y^5PP!SQ0!^;W[87_!5J
MU^/OP;O_  #X0\(WN@QZRJ1ZI?:G.CL(E97,<2I_>*@%B1QD8YR+7[ ?P:UC
MP_\ L@_M#?$?48)+73]<\.7.FZ:LBX\](HI&DE7U7<P4'N5;TKZ3^'/_  2;
M_9[T'Q@S7>MZIXTN;)M[Z+>ZE"$7!_Y:I"JN1G'!('J*^T-4\*^$[CPC/X'N
M;/3X- GTY[1M'0K#']CV[&544C:@!QD=* /R$_X(K_\ )R/BK_L69?\ TI@K
MU3_@N-_QZ_"'_?U/^5M7W1\$/V3_ (0? W6)O$GPZ\,6VE7M]:?9FOK>[EG$
MD)96P"SL,$JIR/2K_P 9/V<OA?\ M.6^DGQOHL'B>+2))EM'CO)$$3-M$BYB
M<9.47(/0K0!^86I_!C5?BI_P2/\ !6KZ+;RWEYX3UF^U26VA&6:V,\R2L!U.
MT,&X[*Q[5QO[!O\ P4=B_9/\&ZIX-\1^&KKQ#X=N+MK^TETZ5$N+>9E574A\
M!E.Q3U!!SUS7[$_"WP)X!^#GA^V^''A".QTNRLTDG31/M?FS*DC%G<J[%R"6
M/)XYKY<^.W_!,']GGQAX@DUVXOKCX<75](TDD6FW\-O:S-U8K%*I"GV3 YZ4
M ?F)^UM^TKK_ .W!\;].O]/T&6TB5$TG0]%A/G3$,Y(W$ ;G=F[<#@=LGWK_
M (*;?#&7X,_!']F?P5<,'N]&T>]M[EE.1YV+9I<'TWLV*_0S]G7]@WX-_LOW
ML6O:#8R:GK[ 1Q:]KMPLTR;N (<!40MG&57<<XR:] ^,W[./PN_:.73I/'F@
M6OB,:*TR6\C7,D?V<MM\Q28W']Q<@],4 >:?\$S_ /DRKX=?]<;C_P!*9:_)
M[QI_RDJO?^RC+_Z6BOW+^$/A[P+X&\&V7A3X?R:?'H.E)MBL["[%P(0[,W)W
M,>26.2:\TF_8<^!>M?$R?Q^WA""Y\5C5?[3EO4OYR!>!P^XH)-H.[!VXQ[4
M0_\ !0K_ ),Q^*O_ &"Q_P"C8Z_-S_@E1\/Q\5='_:"\'EUC;6_"J6,;L<!7
M=I0A/L&P:_7OQMX?\'?&#P_K_@/79+/6K*ZA$.IZ5'=8E5"01O",'3D @\5Q
MOP7_ &8?A-^S7JE[/X%T&#PY?ZTBV\I:]ED>X"98*HD<],D_+0!^)?[+GQ^\
M1?L&_M"ZG<ZUX?FG>!9=&UW19#Y4VP.I.QB.&5D5@>C#V.:]G_;O_P""EUA^
MT]\.+?P'X1\-7NBZ-+<QW>H7FJ.AFE,?*1HJ$@+N.22<G:.!7Z?_ !Z_8^^#
MG[05W#?>//"UI/JQVP1ZI;S-:73]=J&1""_L&S7,>%_^"=_[/G@7P?K6C)X&
MM;FPU%%^VWFJ7,DT^Q&#C$S-F, J"=A7..: /G#_ ((B?\DD^)'_ &'(/_2<
M5^DU>7_ +X-?#'X.^&;R#X6Z=86.C:E<?:)Y-/NVN8YI%&W.\NW0#& :]0H
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C4M6:73HQ%$EV$6*.-S<&&**)GW(<,J E0-V3FOI"BB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139936816313392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Jan. 05, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">NovaBay Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Jan.  05,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">001-33678<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">68-0454536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">2000 Powell Street, Suite 1150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Emeryville<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">94608<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">899-8800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NBY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0001389545<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>nby20240108_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="nby-20240105.xsd" xlink:type="simple"/>
    <context id="d20248K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001389545</identifier>
        </entity>
        <period>
            <startDate>2024-01-05</startDate>
            <endDate>2024-01-05</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20248K">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20248K">0001389545</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20248K">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20248K">2024-01-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20248K">NovaBay Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20248K">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20248K">001-33678</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20248K">68-0454536</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20248K">2000 Powell Street, Suite 1150</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d20248K">Emeryville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20248K">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20248K">94608</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20248K">510</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20248K">899-8800</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20248K">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20248K">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20248K">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20248K">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="d20248K">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20248K">NBY</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20248K">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="d20248K">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MMKC=< :>X!K [RNE[/'!'7#+_T^,_@-02P,$%     @ !4 J6)^@&_"Q @
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M\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @
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M-4H2U\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*1D.QD8E>I6.5Z*U
M.EK >MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*
M$3FQ!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87
M_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    (  5 *E@'04UB@0
M +$    0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#
M%     @ !4 J6-X#4-[M    *P(  !$              ( !KP   &1O8U!R
M;W!S+V-O<F4N>&UL4$L! A0#%     @ !4 J6)E<G",0!@  G"<  !,
M         ( !RP$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "  %
M0"I84Z (\5 $  "K$   &               @($,"   >&PO=V]R:W-H965T
M<R]S:&5E=#$N>&UL4$L! A0#%     @ !4 J6)^@&_"Q @  X@P   T
M         ( !D@P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  %0"I8EXJ[
M',     3 @  "P              @ %N#P  7W)E;',O+G)E;'-02P$"% ,4
M    "  %0"I8.JJBYT !   \ @  #P              @ %7$   >&PO=V]R
M:V)O;VLN>&UL4$L! A0#%     @ !4 J6"0>FZ*M    ^ $  !H
M     ( !Q!$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%
M  @ !4 J6&60>9(9 0  SP,  !,              ( !J1(  %M#;VYT96YT
A7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  \Q,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="nby20240108_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nby.com/20240105/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>nby-20240105.xsd</File>
    <File>nby-20240105_def.xml</File>
    <File>nby-20240105_lab.xml</File>
    <File>nby-20240105_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="nby20240108_8k.htm">nby20240108_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "nby20240108_8k.htm": {
   "nsprefix": "nby",
   "nsuri": "http://www.nby.com/20240105",
   "dts": {
    "schema": {
     "local": [
      "nby-20240105.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "nby-20240105_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "nby-20240105_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "nby-20240105_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "nby20240108_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 26,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.nby.com/20240105/role/statement-document-and-entity-information",
     "longName": "000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "d20248K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "nby20240108_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d20248K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "nby20240108_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.nby.com/20240105/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.nby.com/20240105/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.nby.com/20240105/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.nby.com/20240105/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.nby.com/20240105/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.nby.com/20240105/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.nby.com/20240105/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.nby.com/20240105/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.nby.com/20240105/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.nby.com/20240105/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.nby.com/20240105/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.nby.com/20240105/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.nby.com/20240105/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.nby.com/20240105/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.nby.com/20240105/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.nby.com/20240105/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.nby.com/20240105/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.nby.com/20240105/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.nby.com/20240105/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.nby.com/20240105/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.nby.com/20240105/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.nby.com/20240105/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.nby.com/20240105/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.nby.com/20240105/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.nby.com/20240105/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001437749-24-001062-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-24-001062-xbrl.zip
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M/  8!D_EXS 30>(7$WC2P]$^,>H-4NE_4GGFB;',Q$"I6"23,"?$5+XL,B4
MAO#R(,G'8C/<0E#J?0Y>QTD.8^4JQ<EE', #M2=NDR+"H6 YDZD"(@AO5#2#
MR=+)L( %#\6T&$2A#]\%8>9'2::"G=;C^A:H\>5#JI]1.37-7#D@?3X.+OL
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MTKWJ=OJ>,'B"U(&@S9)(4\AG/X(COH'#O@4%!(_<UX(DAR-4*!@R,>6O$#>
MD,(\$YT;%0.EB [(F4GHI\D .?Y9&-"H9S(; P9&1,$>'I5YOC]-)9Y2)H:
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M7TY)[1OV"1R7==0:HQK+&V;T1->ER5[RW9+IE4JD5G/H4>"^_$!?"PK0I(V
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MBG0#XP8X<KO4!:&4DT< ?B[E998E?E@*8$0E#L]1.(Q#=#CH)(G).++,7RG
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M8:-N.(?'YAE@OI9DXR<AMS-R;LVN-0NT82V0*5FAXR(.DP>I.Q=1,?8\.@^
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MP*ARQ@&*JT6'$GG#M"VG2A9NMUOB3:9RT!$?0O[BX5+YB]<Z*#G#<W7H2HY
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M5S%/T)MM^R)4''MUA(L3-_/5=&LH4V;)Y\S?ZD8NIG3#TYJX;0U)7"N\";$
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M5VX=39U2HK'BE707JA%',U5AE.'8X26 [IFS>9LU7@"WFD*)D];96LE*O*^
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M[W,FBVM:V)P\IL:.06,*)4U3,*TDA@3D(@#)46<86R< "N2 FR$ &4U<-=]
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M8#II^]\'06?0[?5\+Q.()H@P"FV?,O_SI]]_^_@A"+X"!8X$)-YHY0VG<YH
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MF+0PKF+5M5BV2[\@17E6I^4OUA!*BV/%"%V(24@XH<-',=]@)(@U+C '5;3
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MSJ/JKXF5GGF5OM')0@,].QCEKA;^IY4K"#*FDMS2,&;D?]V2ZY$Q]A8/3;_
M<^ELAL#;4=A'$3C16*NP((UO_OTW]10\5F]W02Z7(U!\L6.UCR65V529D[:M
M?W?;ZV^SFN8'C;ZGZ.LB"C!V9?@>BF_J]C#\B4R&S#0Y+!75N2)@32'PQ1UN
MR(T4$SW$$'B,A7:J2, &8$U-2YDM/KJU-&!;JCS:CL\#LO?+3][AT2G>F+C>
MJ:E#IFO@-&#<&/O2L.W"AM.5OE-9L^6Z;M+EO3'"7BS/[(YW]6M1>E(KYMTY
MD;T$3<][9XYKV=/N2X=V4=@RROY7K#0?S);D;W"'1.%5V5KQY"O7/4,0/A9"
MH@#"%PF3-L2*F5D 07*IA&]\<I-*V)=$D&OFK'"&AT\X'(V"' &&,"+9+5>P
M#D2:1CY6$:EOWGS#R?@.7D!EH.QU4K I9SG8H_.<)2ND)4OR.<>WP&$?P^G7
MA>MW;]ZOOT+*)B D4_A(,A!\!-XAO]?E[Q\+N7@KJ70DIIYD#E@!:CBODUPW
MW[6=-YUV\[W3?-MK=R#;#R=TIDZ3Y,N^2);;[90,F06K,IZ> EM#?!?M)]?\
M!]91_Q-(%T1\3GX(WZQ:PN'7\\Y:') 0=V&P,_GH,UP4'E6V4;WJ-RXT&V6Z
MZ/L-#\+/^].>;=:4 ,@V-M;B];<@E*17+^0<O2DW72?-&\ELP6G7^K?N?H]T
MI;2:.Y4DQY*L%J9^)%>%S4MQI68 O+-#'Z.#XTK%/9VPHOF7=TJ2)[%:?B)B
MF3X!LY\^3?9/1O:),7$F^C%\_,#!Z($3PA7GZ*AX/[;-!2DSBR0P+P$OO8=!
M]M!;)(>DN\P7I<<5K</JB@@(>@^.=M)B9=9534Q^.V'@?.$)0)/LB'YYZH>Q
M ODKHKUU["<3F#16)TS@2CPM4(@T;UD$)"%]B2BC<\41<-W)CO@$,5,TA!V#
M#$F*ADCHVYGQKN P%R![1Z?@W&<,/6T00WQWY<>!F$)P=U2U_.!:$6$"5ICF
M0Y:93E5+%"#7R?,YSR!2-:XYEF+, .7?(^2084"AQR2$ET+."A B-A5&?@H\
MO:T>)-A &)E0HC@G''+*]+",0?ABB)G)Y]B\7Q'.B!0S&NH98? H)$9.(!A!
M[TAO3/TA8MH02"V(,(>:*!$&&8("!(@Z'6!'#$B22M&90UX$IZ64B6HDT[&,
M0#(DZ^-<PP$3SZ#I,B<B+4W6[H /013H%.=I4,?!P(P&,8;;EEV^4-I &; 0
M9$3.2J0'9Z\(K G.*-$30?8J^P3?3@)UE2/+.D J[O\%X9(A!MA?_""'#T!"
M%(8A%QX$&@^/04%P&41CAOXF"%' &'!W^ "B;4"7<2,'8Z W_(K'&.Q!K"?)
M).F7@.@0 $2P@=L)J\PTVYYE\(%( Z%!2HKL=B.Z ,$&EZO(HEA8<E,EHM)+
MB=VW:(9[IOL*@G6!JATPY4L^SK9MK1(Q$  EQO%@J/#5..1&G]E8G6F62@[J
MT/P=)M0$['8&.9^ACLS?DT]9.8C#T "X\=QB8@PQS]6:0L818%;;G@YYGVL@
M3<FSF\&$EOGVA"8=\^X>P<;UM*'-0#?OR8<]0(080)@%ZOD%XT>P>'^P>+P+
MP:)]_Z2-;XZJ78L&OZQ>E96^Q+A<1?/HZ<1&3T6,93C>-8/RDK_ Z( 9,1W=
MDH5@E%DN;J)1!"X097Z]20#_ F9G/&\CS>^4-12HY.C"YO;"4N3D!(S&#XNP
MJQ;A!"Q"Z<6;A+?S$I5Y=P,%UT9SB2BJ#2B\ $/Q@H7PX' +0K@7K&G_>#&B
M]N#KU(S@)=>EWY#LO9A^#C+B01!F"J%?XYYSI5B5A,.7X@&&\1Z CY\#X/-%
MRO&EM_;&7GQ5:M]S/8HYB"E>5-=T'#X4\&>@.B7VXV9L^I]#[\ [/L#OX,T5
M"._('$!44E_7F94G6'5_Q0PC)ASM,SUA#-]HM24^?&8CNJ2F5EPNJJ6J3W>;
M_QA.?BGCEYA3JQT]A#G72Y&O";"!'1M9L!R86]I_,<7)FFLEU(OJTXC1$C"'
M7&/U[0+W J2QX'Y.-;6OHN^Q49^9<ACF#4F![<)\;97@YU9)D'Q<9__O0,XZ
M(\=VOL"S\12+?CP@\J:_YQ8)_G?_V:5N4XOSXTB=[T%Y ?[_6TN&$\= 6L *
M"I**7W,,XK2RFZBR@OQ8,B)&6 \U]2WS CO\]9-EOH@&]K..^.:,D+:U.4F
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M>%\V,3,U-3<N:'1M4$L! A0#%     @ !4 J6,U[#7MD P  9@T  !
M         ( !%CD  &YB>2TR,#(T,#$P-2YX<V102P$"% ,4    "  %0"I8
M[VRTF=<$  #B+   %               @ &H/   ;F)Y+3(P,C0P,3 U7V1E
M9BYX;6Q02P$"% ,4    "  %0"I84RY$4/D%  !#/   %
M@ &Q00  ;F)Y+3(P,C0P,3 U7VQA8BYX;6Q02P$"% ,4    "  %0"I805MC
M/W0$  !Z+0  %               @ '<1P  ;F)Y+3(P,C0P,3 U7W!R92YX
M;6Q02P$"% ,4    "  %0"I8V_=X?:,1  "4;   $@              @ &"
K3   ;F)Y,C R-# Q,#A?.&LN:'1M4$L%!@     '  < N@$  %5>      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
